Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers.

Kwon HS, Lee EH, Kim HJ, Park SH, Park HH, Jeong JH, Koh SH, Choi SH, Lee JH

Open source

DOI
10.1002/dad2.12502
Published
2023 Oct-Dec
Container
Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dad2.12502,
  title = {Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers.},
  author = {Kwon HS and Lee EH and Kim HJ and Park SH and Park HH and Jeong JH and Koh SH and Choi SH and Lee JH},
  year = {2023},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.12502},
  url = {https://doi.org/10.1002/dad2.12502}
}

RIS

TY  - JOUR
TI  - Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers.
AU  - Kwon HS
AU  - Lee EH
AU  - Kim HJ
AU  - Park SH
AU  - Park HH
AU  - Jeong JH
AU  - Koh SH
AU  - Choi SH
AU  - Lee JH
PY  - 2023
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.12502
UR  - https://doi.org/10.1002/dad2.12502
ER  - 

APA

HS, K., EH, L., HJ, K., SH, P., HH, P., JH, J., SH, K., SH, C., & JH, L. (2023). Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.12502

Source records